188
Participants
Start Date
July 31, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2016
NDV-3A
0.5mL injection IM
NDV-3
0.5mL injection IM
Placebo
aluminum hydroxide and buffered saline
SUNY Downstate Medical Center, Brooklyn
Suffolk Ob/Gyn, Port Jefferson
Drexel University College of Medicine, Philadelphia
Magnolia OB/GYN Research Center, LLC, Myrtle Beach
Community Medical Research, Miami Beach
Miami Clinical Research, LLC, Miami
Community Medical Research LLC, North Miami
KO Clinical Research, LLC, Fort Lauderdale
Women's Medical Research Group, LLC, Clearwater
WSU Physician's Group, Detroit
Saginaw Valley Medical Research Group, LLC, Saginaw
MedPharmics, Metairie
Arkansas Women's Center, Little Rock
Discovery Clinical Trials- HCWC, LLC, Dallas
TMC Life Research, Houston
Advanced Research Associates, Corpus Christi
Precision Trials LLC, Phoenix
McCann MD Research, Inc., Torrance
Women's Health Care Research Corp, San Diego
Lawrence OB/Gyn Clinical Research, Lawrenceville
Lead Sponsor
NovaDigm Therapeutics, Inc.
INDUSTRY